These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 11332874)
1. Systemic bioavailability of nasally applied chlorphenamine maleate (0.4% nasal spray) relative to tablets administered perorally. Van Toor BS; Buchwald A; Stengele E; Trenk D; Gercek C; de Mey CM Int J Clin Pharmacol Ther; 2001 Apr; 39(4):173-8. PubMed ID: 11332874 [TBL] [Abstract][Full Text] [Related]
2. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions. Chen C; Bujanover S; Kareht S; Rapoport AM Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369 [TBL] [Abstract][Full Text] [Related]
3. Formulation and stability study of chlorpheniramine maleate nasal gel. Soliman II; Soliman NA; Abdou EM Pharm Dev Technol; 2010; 15(5):484-91. PubMed ID: 20735301 [TBL] [Abstract][Full Text] [Related]
4. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions. Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers. Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017 [TBL] [Abstract][Full Text] [Related]
6. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728 [TBL] [Abstract][Full Text] [Related]
7. Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials. Metzmann K; Schnell D; Jungnik A; Ring A; Theodor R; Hohl K; Meinicke T; Friedrich C Int J Clin Pharmacol Ther; 2014 Jul; 52(7):549-63. PubMed ID: 24755124 [TBL] [Abstract][Full Text] [Related]
8. Improved pharmacokinetics of sumatriptan with Breath Powered™ nasal delivery of sumatriptan powder. Obaidi M; Offman E; Messina J; Carothers J; Djupesland PG; Mahmoud RA Headache; 2013 Sep; 53(8):1323-33. PubMed ID: 23992438 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjects. Strenkoski-Nix LC; Ermer J; DeCleene S; Cevallos W; Mayer PR Am J Health Syst Pharm; 2000 Aug; 57(16):1499-505. PubMed ID: 10965395 [TBL] [Abstract][Full Text] [Related]
10. Influence of food on the oral bioavailability of rupatadine tablets in healthy volunteers: a single-dose, randomized, open-label, two-way crossover study. Solans A; Carbó ML; Peña J; Nadal T; Izquierdo I; Merlos M Clin Ther; 2007 May; 29(5):900-908. PubMed ID: 17697908 [TBL] [Abstract][Full Text] [Related]
11. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics. Bramer SL; Forbes WP Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883 [TBL] [Abstract][Full Text] [Related]
12. A Phase I Study of the Pharmacokinetics and Pharmacodynamics of Intranasal Doxylamine in Subjects with Chronic Intermittent Sleep Impairment. Allison M; Hale C Drugs R D; 2018 Jun; 18(2):129-136. PubMed ID: 29671128 [TBL] [Abstract][Full Text] [Related]
13. A Phase I, Open-label, Randomized, 2-Way Crossover Study to Evaluate the Relative Bioavailability of Intranasal and Oral Varenicline. Nau J; Wyatt DJ; Rollema H; Crean CS Clin Ther; 2021 Sep; 43(9):1595-1607. PubMed ID: 34456060 [TBL] [Abstract][Full Text] [Related]
14. A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults. Munjal S; Gautam A; Offman E; Brand-Schieber E; Allenby K; Fisher DM Headache; 2016 Oct; 56(9):1455-1465. PubMed ID: 27613076 [TBL] [Abstract][Full Text] [Related]
15. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study. Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325 [TBL] [Abstract][Full Text] [Related]
16. Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers. Bass A; Stark JG; Pixton GC; Sommerville KW; Zamora CA; Leibowitz M; Rolleri R Clin Ther; 2012 Jul; 34(7):1601-12. PubMed ID: 22717418 [TBL] [Abstract][Full Text] [Related]
17. Absolute bioavailability of intranasal fluticasone furoate in healthy subjects. Allen A; Down G; Newland A; Reynard K; Rousell V; Salmon E; Scott R Clin Ther; 2007 Jul; 29(7):1415-20. PubMed ID: 17825692 [TBL] [Abstract][Full Text] [Related]